Manama, October 6 / BNA / In line with the directives of His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince and Prime Minister, the Ministry of Health has begun providing a revolutionary drug treatment for crizanlizumab patients. Those suffering from sickle cell disease.
The directives are in line with the commitment of His Highness the Crown Prince and the Prime Minister to maintain public health as a top priority.
The UK’s National Health Service recently started offering the treatment, the first treatment for the disease in 20 years.
Crizanlizumab can be used by drip transfusion in sickle cell patients over 16 years of age. The revolutionary drug works by binding to a protein in the blood cells to prevent a restriction in the supply of blood and oxygen.
insult